Cyllene Therapeutics

Paris, IDF

UEI
TTTFQ5CCENH4
CAGE
FC2H4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Other
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
13 Rue Watt, 75013 Paris, France

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cyllene Therapeutics's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
FIH phase 1B/2A dose escalation study of EG110A, a nonreplicative HSV 1-derived gene therapy, via intradetrusor… Grant · HT94252510505 Defense Health Agency $3,165,836

Quick answers

What is Cyllene Therapeutics's UEI?

Cyllene Therapeutics's Unique Entity ID (UEI) in SAM.gov is TTTFQ5CCENH4.

What is Cyllene Therapeutics's CAGE code?

Cyllene Therapeutics's CAGE code is FC2H4.

What is Cyllene Therapeutics's primary NAICS code?

Cyllene Therapeutics's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Cyllene Therapeutics located?

Cyllene Therapeutics's physical address in SAM.gov is 13 Rue Watt, 75013 Paris, France.

Is Cyllene Therapeutics registered in SAM.gov?

Yes. Cyllene Therapeutics's SAM.gov registration is active through October 9, 2027.

What is Cyllene Therapeutics's most recent federal award?

Cyllene Therapeutics's most recent federal grant award is FIH phase 1B/2A dose escalation study of EG110A, a nonreplicative HSV 1-derived gene therapy, via intradetrusor… (HT94252510505), from Defense Health Agency, on July 1, 2025.

On GovTribe

See Cyllene Therapeutics's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login